Summary: Using multiparametric MRI as the first diagnostic tool for muscle-invasive bladder cancer significantly reduces treatment time by 45 days, modernizes care, and lowers the need for invasive surgical procedures.

Key Takeaways

  • Using multiparametric MRI as the first diagnostic tool reduces treatment time for muscle-invasive bladder cancer by 45 days, significantly faster than traditional staging methods.
  • MRI pre-biopsy offers a less invasive and cost-effective alternative to the standard TURBT surgical procedure, saving operating room resources and reducing unnecessary surgeries for 1 in 7 patients.
  • The study highlights a modernized diagnostic pathway for aggressive bladder cancer, potentially improving patient outcomes and transforming care practices.

——————————————————————————————————————————————————————————

Patients with muscle-invasive bladder cancer, a common and aggressive form of the disease, could get treatment significantly faster thanks to new research suggesting that MRI and biopsy could streamline the diagnostic process.

Published in the Journal of Clinical Oncology, a study led by the University of Birmingham’s Bladder Cancer Research Center (BCRC) and Cancer Research UK Clinical Trials Unit found that using multiparametric MRI as the first diagnostic tool dramatically reduces the time to treatment compared to traditional surgical methods.

The study, funded by the UK National Institute for Health and Care Research, enrolled 143 patients with suspected bladder cancer. Participants were randomly assigned to either undergo the standard transurethral resection of bladder tumor (TURBT) procedure or begin with an MRI scan to guide next steps.

Modernizing Bladder Cancer Care

Results showed that patients who underwent an initial MRI reached their correct treatment in a median of 53 days—45 days faster than the median of 98 days with traditional staging. TURBT, a surgical procedure requiring anesthesia, involves using a telescope to examine the bladder and remove tumor tissue, whereas MRI offers a less invasive, cost-effective alternative.

“Bladder cancer care has remained largely unchanged for over a century,” says Rik Bryan, PhD, professor in urothelial cancer research and director of BCRC. “Introducing MRI in the diagnostic pathway not only speeds up treatment but also modernizes bladder cancer care, giving patients a better chance of responding well to treatment.”

Chief investigator Nick James, MD, a professor of prostate and bladder cancer research at The Institute of Cancer Research, London, adds, “Using MRI pre-biopsy reduces surgical procedures for 1 in 7 patients, saving costs and freeing up operating rooms. This pathway could transform care for aggressive bladder cancer.”